"Highlighting a ton of open questions": Top journal's special issue on women's health examines the latest discoveries on chronic pain and menopause.

WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.

Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.

In Washington, Eric Cantor will confront bipartisan backlash over rising health care costs.

An investor lawsuit against UnitedHealth Group will move forward after a federal judge declined the company’s motion to dismiss allegations.

Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what MAHA has become.

Federal health officials want to speed up clinical research to compete with countries like China.

An investigational combination therapy from Eli Lilly led to significant weight loss in a mid-stage study, but high discontinuation rates raise questions about tolerability.

New research involving giving mice a human cell-based cortex brings to mind “Flowers for Algernon” and “Pinky and the Brain,” writes STAT Lab Dish columnist Paul Knoepfler.

Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing government health coverage starting Oct. 1.

About half of rural voters identify with MAHA movement, but most said President Trump’s health care policies have not benefited their communities, according to a new poll.

Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.

STAT trust-in-science reporter Nick Florko speaks with sociologist Jennifer Reich about why some parents hesitate to vaccinate their children, and why dismissing their concerns can be counter-productive. Florko and Reich explore why parents may delay v...

YouTube video by STAT

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

STAT trust-in-science reporter Nick Florko speaks with sociologist Jennifer Reich about why some parents hesitate to vaccinate their children, and why dismissing their concerns can be counter-productive. Florko and Reich explore why parents may delay v...

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.

The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care in federal prison.

Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Our finding was remarkable because it had remained hidden within one of the best-studied organs in medical history.

“Arguing over whether someone died ‘with’ or ‘of’ a disease gets us stuck on the last thing that happened.” write two Unbiased Science scientists.

President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.

The Readout LOUD is going international this week with a dispatch from Shanghai, along with notes on the FDA's Overton era.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

Advanced Research Projects Agency for Health is planning a total-lifespan research project on autism: A Q&A with its leader, Russell Shilling.

Virtually all of the 175,000 public comments on a 2022 FDA proposal to ban menthol cigarettes were form letters, most echoing tobacco industry talking points.

At least five candidates are in the running to become the next director-general of the WHO, a job that will come with extraordinary challenges.

Senators focused on asking Overton about vaccines, abortion, and vapes.

President Trump and his aides boasted that every U.S. state wanted to participate in a drug pricing initiative through Medicaid. Several states said they weren't sure yet.

Klomp, a behind-the-scenes HHS power player, is likely to be confirmed as second-in-command to RFK Jr.

What to know about Dr. Heidi Overton, Trump's pick to run the FDA, including her medical background and career trajectory.

What to know about Dr. Heidi Overton, Trump's pick to run the FDA, including her medical background and career trajectory.

Heidi Overton, Trump's pick for FDA head, will face questions at a Senate hearing. Follow along with our live blog.

A planned EO that would have greatly enhanced White House influence over grants at the NIH is “looking dead,” a source said.

Exclusive: Heidi Overton plans to tell senators she will speed up biomedical research, working with FDA staff.

A conversation on the future of biosimilars as competition grows and policy continues to evolve.